Your browser doesn't support javascript.
loading
Recommendations for the definition, evaluation, and treatment of nail psoriasis in adult patients with no or mild skin psoriasis: A dermatologist and nail expert group consensus.
Rigopoulos, Dimitrios; Baran, Robert; Chiheb, Soumiya; Daniel, Carlton Ralph; Di Chiacchio, Nilton; Gregoriou, Stamatis; Grover, Chander; Haneke, Eckart; Iorizzo, Matilde; Pasch, Marcel; Piraccini, Bianca Maria; Rich, Phoebe; Richert, Bertrand; Rompoti, Natalia; Rubin, Adam I; Singal, Archana; Starace, Michela; Tosti, Antonella; Triantafyllopoulou, Ioanna; Zaiac, Martin.
Afiliação
  • Rigopoulos D; University Hospital of Venereal and Skin Diseases A. Sygros, Athens, Greece.
  • Baran R; University of Franche-Comté, Nail Disease Center, Cannes, France.
  • Chiheb S; Faculty of Medicine and Pharmacy, University Hassan II, Casablanca, Morocco.
  • Daniel CR; University of Mississippi Medical Center, Jackson, Mississippi; University of Alabama, Birmingham, Alabama.
  • Di Chiacchio N; Department of Dermatology, Hospital do Servidor Público Municipal de São Paulo, São Paulo, Brazil.
  • Gregoriou S; University Hospital of Venereal and Skin Diseases A. Sygros, Athens, Greece.
  • Grover C; Department of Dermatology and STD, University College of Medical Sciences and GTB Hospital, Delhi, India.
  • Haneke E; Department of Dermatology, Inselspital, University Bern, Bern, Switzerland; Centro de Dermatología, Instituto CUF, Porto, Portugal.
  • Iorizzo M; Private dermatology practice, Bellinzona, Switzerland.
  • Pasch M; Department of Dermatology, Radboud University Medical Center, Nijmegen, the Netherlands.
  • Piraccini BM; Department of Specialized, Experimental, and Diagnostic Medicine, University of Bologna, Bologna, Italy.
  • Rich P; Oregon Health and Science University, Portland, Oregon.
  • Richert B; Saint Pierre-Brugmann and Queen Fabiola Children's University Hospitals, Université Libre de Bruxelles, Brussels, Belgium.
  • Rompoti N; University Hospital of Venereal and Skin Diseases A. Sygros, Athens, Greece. Electronic address: natalia.rompoti@gmail.com.
  • Rubin AI; Department of Dermatology, Hospital of the University of Pennsylvania, Children's Hospital of Philadelphia, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.
  • Singal A; Department of Dermatology and STD, University College of Medical Sciences and GTB Hospital, Delhi, India.
  • Starace M; Department of Specialized, Experimental, and Diagnostic Medicine, University of Bologna, Bologna, Italy.
  • Tosti A; University of Miami Miller School of Medicine, Miami, Florida.
  • Triantafyllopoulou I; Private dermatology practice, Athens, Greece.
  • Zaiac M; Greater Miami Skin and Laser Center, Department of Dermatology, Herbert Wertheim College of Medicine, Florida International University, Miami, Florida.
J Am Acad Dermatol ; 81(1): 228-240, 2019 Jul.
Article em En | MEDLINE | ID: mdl-30731172
Nail involvement in psoriasis is common, and the severity of it does not always parallel the intensity of cutaneous disease. We created a consensus group, of which the aim was to provide practical recommendations for the treatment of nail psoriasis in patients without skin psoriasis or with mild skin lesions with no indication for a systemic treatment. This collaborative process was conducted by an international panel of dermatologists with special expertise in nail disorders, using formal consensus methods. During this process, the panel strived to establish an agreement regarding the definition of nail psoriasis, the severity of nail psoriasis, and treatment response. Treatment recommendations are provided regarding nail psoriasis severity and matrix or bed involvement. Few-nail disease was considered as nail psoriasis affecting ≤3 nails. In the case of matrix involvement only, intralesional steroid injections were considered the treatment of choice. Topical steroids alone or in combination with topical vitamin D analogues were suggested for nail psoriasis limited to the nail bed. For the systemic treatment of nail psoriasis acitretin, methotrexate, cyclosporine, small molecules, and biologics may be employed.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Psoríase / Guias de Prática Clínica como Assunto / Fármacos Dermatológicos / Doenças da Unha Tipo de estudo: Diagnostic_studies / Etiology_studies / Guideline / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Am Acad Dermatol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Grécia País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Psoríase / Guias de Prática Clínica como Assunto / Fármacos Dermatológicos / Doenças da Unha Tipo de estudo: Diagnostic_studies / Etiology_studies / Guideline / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Am Acad Dermatol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Grécia País de publicação: Estados Unidos